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Abstract
Background: A new hypervirulent (hypermucoviscous) clinical variant of Klebsiella pneumoniae (hvKP) has emerged over the
last decade. Our goal is to identify new mechanisms, which increase the virulence hvKP compared to ‘‘classic’’ K.
pneumoniae (cKP).
Methodology/Principal Findings: Various growth assays were performed in human ascites, human serum, and laboratory
medium with the hvKP strain hvKP1 (wt), randomly chosen blood isolates of cKP strains (cKP1-4), and mutant constructs
deficient in the secretion of selected compounds. An in vivo mouse model that mimics infection due to hvKP and a
quantitative siderophore assay were also used. It was established that a molecule(s)/factor(s) was secreted by hvKP1
significantly enhanced its growth and/or survival in human ascites. This molecule(s)/factor(s) also increased the growth and/
or survival of hvKP1 in serum ex vivo and in an in vivo mouse model that measures metastatic spread after subcutaneous
challenge, thereby further establishing biologic significance. Although features such as a size of ,3kD, heat stability, and
growth characteristics in ascites suggested this molecule(s) was a quorum-sensing compound, data presented
demonstrates that this molecule(s)/factor(s) is involved in iron uptake and is likely a siderophore(s) or another iron-
acquisition molecule. Although it is known that iron acquisition is critical for virulence, a novel aspect of this observation is
that hvKP1 produces quantitatively more siderophores that appear to be biologically more active (increased affinity for iron
or more resistant to host factors) than those produced by cKP strains.
Conclusions/Significance: The data presented delineates a new mechanism by which hvKP increases its pathogenic
potential compared to cKP strains. This paradigm may be broadly applicable to other extraintestinal gram-negative bacilli.
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Introduction
Until recently, most Klebsiella infections were due to ‘‘classic’’ K.
pneumoniae (cKP) strains. Particularly in developed Western
countries most infections occurred in hospitals and long-term care
facilities. Pneumonia, urinary tract infection, abdominal infection,
intra-vascular device infection, surgical site infection, soft tissue
infection, and subsequent bacteremia were the most common
clinical syndromes.
However a new, hypervirulent clinical variant of Klebsiella
pneumoniae (hvKP) has emerged over the last decade. Initial reports
were from the ‘‘Pacific Rim’’, but more recently hvKP has been an
emerging pathogen in the United States, Canada, Europe, Israel,
South Africa, Australia and elsewhere [1,2,3,4,5]. In fact, a case of
hvKP infection in Buffalo, New York, USA was one of the
motivating factors for our laboratory to study hvKP [6]. At first,
infection due to hvKP was clinically defined and distinguished
from traditional infections due to cKP by: 1) presenting as
community-acquired liver abscess (CA-PLA), 2) affecting patients
lacking a history of hepatobiliary disease, and 3) a propensity for
causing metastatic spread to distant sites in 11-80% of cases (e.g.
lungs, pleura, prostate, bone, joints, kidneys, spleen, muscle/fascia,
soft-tissue, skin, eyes, and central nervous system (CNS) [2,4,7,
8,9,10,11,12,13]. hvKP infection frequently occurs in diabetics
and Asians, but hosts are often young and healthy and infections
are described in all ethic groups. hvKP is associated with a
significant mortality rate, ranging from 3–32% [7,9,10,14,
15,16]. Further, survivors with metastatic spread often suffer
catastrophic morbidity such as loss of vision and neurologic
sequelae [7,10]. From a clinical perspective, hvKP possesses novel
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infection (e.g. liver abscess) is an unusual occurrence for a healthy
individual. Further, although metastatic spread is common for
certain gram-positive pathogens such as Staphylococcus aureus and
Streptoccocci, it is uncommon for extraintestinal GNB such as
Klebsiella.
The lack of an unequivocal genotypic/phenotypic marker(s) for
hvKP has precluded a comprehensive understanding of the
prevalence and spectrum of hvKP disease. Although there is no
clear surrogate marker for hvKP strains, a hypermucoviscous
phenotype has been associated with strains that cause CA-PLA.
This phenotype has been semi-quantitatively defined by a positive
‘‘string test’’ (formation of a viscous string .5mm in length when
bacterial colonies on an agar plate are stretched by an inoculation
loop). However, if a hypermucoviscous phenotype is a valid marker,
the spectrum and number of infections due to hvKP is more
extensive than appreciated. A variety of community-acquired,
primary, non-hepatic infections including renal, deep neck, and
parotid gland abscesses; mycotic aneurysm, osteomyelitis, subdural
empyema, pulmonary empyema, and septic arthritis without
concomitant hepatic abscess have been described [14,17]. In a
series of 200 cases of community acquired KP bacteremia, 42%
(83/200) possessed a hypermucoviscous phenotype. Of these 83
cases, 23% were primary bacteremias, 21% were primary
pneumonias, 11% were UTIs, 2% were spontaneous bacterial
peritonitis, and 37% were the pathognomic CA-PLA 6 metastatic
spread to the CNS, eye, or pleural space [18]. The 14-day mortality
in these 83 patients was 27%. A number of adult cases of primary
community-acquired meningitis due to K. pneumonia have been
reported from Taiwan, with mortality rates ranging from 30–83%
and survivors suffering significant neurologic sequelae [16,19,
20,21]. Likewise, K. pneumonia was the second most common
pathogen responsible for splenic abscess in a recent series from
Korea [22]. The presence or absence of a hypermucoviscous
phenotype was not reported in these studies, but since KP is an
exceedingly rare cause of primary meningitis and splenic abscess in
adults, it is tempting to speculate that hvKP was the responsible
pathogen.
Compounding an already challenging clinical situation is the
recent propensity of K. pneumoniae to become multi-dug resistant
(MDR), including the acquisition of extended-spectrum b-lactamases
and carbapenemases, such as the recently described New Delhi
metallo-b-lactamase (NDM-1) [23]. Some cases of infection due to
hvKPcausedbyMDR-strainshavealreadybeendescribed[24]and
asexpected, outcome is worsewithinappropriate treatment [25].As
a result, management of infections due to hvKP will become
extremely challenging and morbidity and mortality rates will
increase. The confluence of hypervirulence and MDR in hvKP has
the potential to create a ‘‘post-antibiotic’’ scenario; similar to what
was feared with methicillin resistant S. aureus (MRSA) but was never
realized. Therefore, enhancing our understanding of this highly
virulent pathogen is critical. In this report we describe a novel
mechanism that increases the virulence of hvKP and discuss these
new finding within the context of what is known about the virulence
of hvKP.
Results
hvKP1, when sub-cultured from LB medium, is able to
grow in human ascites at a starting inoculum of 10
7 cfu/
ml, but not at 10
3 and 10
5 cfu/ml
Human ascites is a body fluid that mimics the environment
within the human host in which extracellular pathogens such as
Klebsiella grow and survive. The growth and/or survival of
hvKP1 was characterized in ascites (batch 2) after overnight
growth in LB medium. Somewhat surprisingly, growth was limited
when the starting inoculum was 10
3 cfu/ml and 10
5 cfu/ml, but
not 10
7 cfu/ml (Figure 1A). It was then hypothesized that this
growth difference may be due to the bactericidal effects of
complement, which is present in ascites. So next, the growth and/
or survival of hvKP1 (sub-cultured from LB medium) was
characterized in the same batch of ascites that had been heated
at 56uC for 30 minutes (which inactivated the bactericidal activity
of complement). However, the growth and/or survival of hvKP1
was again limited when the starting inoculum was 10
3 cfu/ml and
10
5 cfu/ml, but not 10
7 cfu/ml (Figure 1B). By contrast, hvKP1








9 cfu/ml respectively (Figure 1C). These data
lead to the hypothesis that quorum sensing or a quorum sensing-
like mechanism was responsible for the observed growth patterns
in human ascites.
The addition of conditioned medium generated by
hvKP1 grown in human ascites and minimal medium, but
not LB broth, facilitates growth of hvKP1 in human
ascites at a starting inoculum of 10
3 cfu/ml
Quorum sensing is a cell-to-cell signaling mechanism that
facilitates communal growth via secreted molecules termed
autoinducers (AI) [26,27,28]. A high density of organisms is often
requisite for the concentration of the secreted AI to achieve the
necessary concentration to regulate gene expression. Such concen-
trations are often achieved in late logarithmic-to-stationary phase
grown cells. Therefore, we generated bacterial-free supernatant
from stationary phase hvKP1 grown in human ascites, minimal
medium, and LB broth (conditioned media) to test its effects on the
growth of hvKP1 in human ascites at a starting inoculum of
approximately 10
3 cfu/ml. When grown in two independent
batches (batches 1 and 2) of human ascites with final concentrations
of 5%, 10%, and 25% homologous conditioned ascites, a significant
increase in the growth and/or survival of hvKP1 was observed
compared to unconditioned ascites and a trend was observed with
1% supplementation (Figure 2). By contrast, no growth was
observed with final concentrations of 0% conditioned ascites and
25% of unconditioned ascites heated to 56uC for 30 minutes. This
later condition served as a control for the addition of conditioned
ascitesdilutingcomplement-mediatedbactericidalactivityinascites.
These data support the hypothesis that a factor is present in
conditioned ascites that promotes the growth and/or survival of a
low starting inoculum of hvKP1 in human ascites.
Next, the effect of LB (iron replete) and M9 (partially iron
depleted) conditioned media (generated by growth of hvKP1 in
these media overnight) on the growth and/or survival of hvKP1 in
human ascites (batch 2) at a starting inoculum of approximately 10
3
cfu/ml was assessed. Growth and/or survival was not affected when
hvKP1 was grown in human ascites withfinalconcentrations of1%,
5%, and 10% conditioned LB medium or unconditioned media. By
contrast, a significant increase in the growth and/or survival of
hvKP1 was observed when grown in human ascites with final
concentrations of 10% conditioned minimal medium, a trend
towards increased growth/survival was observed with final con-
centrations of 5% conditioned minimal medium, but not 1% of
conditioned minimal medium compared to the respective concen-
trations of unconditioned minimal medium (Figure 3). However, a
higher final concentration of conditioned minimal medium was
necessary, compared to conditioned ascites. These data support the
hypothesis that a factor is present in conditioned minimal medium,
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7 cfu/ml. Panel A: 100% human ascites, Panel B: 100% human ascites heated at 56uC for 30 minutes, and Panel C: M9 minimal medium.
Data are Mean 6 S.E.M.; N=3.
doi:10.1371/journal.pone.0026734.g001
Figure 2. Growth and/or survival of hvKP1 grown in human ascites supplemented with varying concentration of homologous,
conditioned ascites. The growth and/or survival of hvKP1 was assessed at 0, 3, 6, and 24 hours in 100% human ascites supplemented with
homologous conditioned ascites resulting in final concentrations of 0%, 1%, 5%, 10%, and 25%. Growth and/or survival was also assessed in ascites
supplemented with 25% unconditioned ascites heated at 56uC for 30 minutes to control for a possible effect of conditioned ascites diluting
complement-mediated bactericidal activity. Panel A: ascites batch 1. Panel B: ascites batch 2. Supplementation with 5%, 10%, and 25% conditioned,
homologous ascites, compared to 0%, resulted in a significant increase in growth and/or survival for both batches of ascites (* P,0.05/4) and
supplementation with 1% conditioned, homologous ascites resulted in a trend for increased growth and/or survival (# P.0.05/4 and,0.05). Data are
Mean 6 S.E.M.; N=2–3.
doi:10.1371/journal.pone.0026734.g002
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survival of a low starting inoculum of hvKP1 in human ascites and
that this factor may be iron-regulated. These data also demonstrate
that the factor is derived from hvKP1 since there are no host factors
present in minimal medium.
The presence conditioned ascites or minimal medium
increases the growth and/or survival of hvKP1 in 80%
human serum
Human ascites contains a variable amount of complement. The
ability of conditioned ascites and minimal medium to increase
growth and/or survival of hvKP1 in this clinically relevant body
fluid is biologically significant. To extend this observation, the
effect of conditioned ascites and minimal medium was assessed in
80% human serum, a more quantitatively defined and challenging
growth environment for hvKP1. A starting inoculum of approx-
imately 1610
5 cfu/ml was chosen since hvKP1 did not grow in
ascites at this titer and our group for serum sensitivity experiments
has used this inoculum historically [6,29,30]. The growth and/or
survival of hvKP1 when grown in 80% serum plus final
concentrations of either 5% conditioned ascites (batch 2) or 10%
conditioned minimal medium was significantly greater than in
80% serum plus either 5% unconditioned ascites or 10%
unconditioned minimal medium respectively (Figure 4). These
data further support the biologic significance of the effect of
conditioned ascites or minimal medium on the growth and/or
survival of hvKP1 in the clinically relevant human body fluid.
hvKP1 grown in conditioned ascites, compared to
unconditioned ascites, were more virulent in a mouse
systemic infection model
As the next step in establishing biologic relevance of the effect of
growing hvKP1 in conditioned compared to unconditioned
ascites, a mouse systemic infection model developed by our group
was used. This model mimics metastatic spread of hvKP, which
occurs in human infection. In addition, mice are challenged via a
physiologically relevant route that avoids the confounding effect of
a potential cytokine ‘‘storm’’ (see Methods for additional details).
Outbred CD1 mice were challenged subcutaneously with
3.15610
4 cfu of hvKP1 grown in human ascites (batch 2) with a
final concentration of 5% homologous conditioned ascites or with
1.89610
4 cfu or 1.65610
5 of hvKP1 grown in unconditioned
human ascites (batch 2). The metastatic spread of hvKP1 from the
subcutaneous compartment to the blood, eye, kidney, spleen, liver
and lungs was greater when hvKP1 was grown in the presence of
conditioned ascites, compared to unconditioned ascites at all times
post-bacterial challenge (24 and 48 hours) and this difference was
statistically significant or demonstrated a trend towards signifi-
cance for most comparisons (Figure 5). These data further
establish the ability of conditioned ascites to enhance the virulence
of hvKP1 in a clinically relevant in vivo model.
The AI-2 and AI-3 quorum-sensing molecules do not
appear to be the mediators in hvKP1 generated
conditioned ascites and minimal medium that enhance
the growth and/or survival of hvKP1
The next important question to resolve was the nature of the
compound present in conditioned ascites or minimal medium that
enhanced the growth and/or survival of hvKP1 in human ascites
and serum ex vivo and in a mouse infectionmodel.Data from initial
growth experiments (Figure 1 A, B) suggested the compound was an
AI molecule that mediated a quorum sensing response. To date, AI
signaling molecules in GNB have been categorized into AI-1, AI-2,
and AI-3 [27]. LuxS is an enzyme, which has been shown to
generate AI-2 in Vibrio species [26], however, it also serves as a key
enzyme in the activated methyl cycle which generates the methyl
donor S-adenosyl-L-methione [28]. The role of AI-2 mediating
quorum sensing in non-Vibrio genera has recently been questioned
[27,28,31,32]. However since luxS is present in Klebsiella and has
been implicated in biofilm formation [33,34], we assessed whether
LuxS generated AI-2signaling molecules may be responsible for the
observed effects of conditioned ascites and minimal medium
described above. A luxS gene disruption was generated in hvKP1
(hvKP1DluxS). Conditioned ascites (batch 2) was generated by
overnight growth of hvKP1 and hvKP1DluxS. However, the growth
and/or survival of hvKP1 when inoculated at low titer into human
ascites (batch 2) was similarly increased with a final concentration of
5% conditioned ascites medium regardless of whether hvKP1 or
hvKP1::luxS was used for its generation (Figure 6A). Therefore,
these data did not implicate an AI-2 quorum-sensing system as a
mediator of conditioned ascites-mediated increased growth and/or
survival.
Figure 3. Growth/survival of hvKP1 grown in human ascites supplemented with hvKP1 generated M9 and LB conditioned media.
The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) supplemented with unconditioned (uncond) or hvKP1
generated conditioned (cond) rich laboratory (LB) or minimal (M9) media resulting in final concentrations of 0%, 1%, 5%, and 10%. Panel A: ascites
supplemented with conditioned rich laboratory medium (LB). Panel B: ascites supplemented with conditioned minimal medium (MM).
Supplementation with 10% conditioned MM compared to 0% resulted in a significant increase in growth/survival (* P,0.05/3) and supplementation
with 5% conditioned MM compared to 0% resulted in a trend towards an increase in growth/survival (# P.0.05/3 and,0.05). Data are Mean 6
S.E.M.; N=2.
doi:10.1371/journal.pone.0026734.g003
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responsible. Both epinephrine (at 50nM) and norepinephrine have
been shown to serve as signaling molecules for AI-3 quorum-
sensing system [31,35]. Therefore, we assessed the effect of
epinephrine on the growth and/or survival of hvKP1 when
inoculated at low titer into human ascites (batch 2). No significant
Figure 5. hvKP1 grown in conditioned ascites, compared to unconditioned ascites, resulted in significantly greater growth and/or
survival and dissemination after SQ challenge of CD1 mice. Animals were challenged subcutaneously with 3.15610
4 cfu of hvKP1 grown in
conditioned ascites (batch 2) and 1.89610
4 cfu or 1.65610
5 cfu of hvKP1 grown in unconditioned ascites (batch 2)(n=6 for each condition and
challenge inocula). Bacterial titers were enumerated in blood and various organs at 24 and 48 hours after challenge. After blood was obtained for
culture, the vasculture was ‘‘flushed’’ with 1xPBS and organs were subsequently harvested. Comparisons were between hvKP1 grown in conditioned
ascites and hvKP1 grown in unconditioned ascites. * P,0.05/2; # P.0.05/2 but ,0.1. Data are Mean 6 S.E.M. for n= 3.
doi:10.1371/journal.pone.0026734.g005
Figure 4. The survival of hvKP1 in 80% human serum is significantly increased when serum is supplemented with hvKP1 generated
conditioned ascites or minimal medium. The survival of hvKP1 in 80% active or heat inactivated (56uC for 30 minutes (D56uC)) human serum
was assessed at 0, 3, 6, and 24 hours. Growth in heat inactivated serum served was a positive control that established that decreased survival was due
to complement-mediated bactericidal activity. The active serum was supplemented with final concentrations of: 1) 20% 16phosphate-buffered saline
(PBS), 2) 15% PBS plus 5% unconditioned ascites (uncond-ascites; batch 2), 3) 10% PBS and 10% unconditioned M9 minimal medium (uncond-MM), 4)
15% PBS and 5% conditioned ascites (cond-ascites; batch 2), and 5) 10% PBS and 10% conditioned M9 minimal medium (cond-MM). The heat
inactivated serum was supplemented with final concentrations of: 1) 15% PBS and 5% unconditioned ascites (uncond-ascites) and 2) 15% PBS and 5%
conditioned ascites (cond-ascites). Survival of hvKP1 was significantly increased when 80% active serum was supplemented with hvKP1-conditioned
ascites compared to unconditioned ascites (*P,0.05/1) or when supplemented with conditioned M9 minimal medium compared to unconditioned
M9 minimal medium (*P,0.05/1). Survival of hvKP1 was significantly increased when 80% heat inactivated serum was supplemented with hvKP1-
conditioned ascites compared to unconditioned ascites (*P,0.05/1). Data are Mean 6 S.E.M.; N=3–4.
doi:10.1371/journal.pone.0026734.g004
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successfully, nor at 500nM (Figure 6B). Therefore, these data did
not implicate the AI-3 quorum-sensing system as a mediator of
conditioned ascites-mediated increased growth and/or survival.
The mediators present in conditioned minimal medium
and ascites that enhance the growth and/or survival of
hvKP1 are ,3kD and heat stable
To gain insight on the nature of the growth and/or survival-
enhancing factor present in conditioned human ascites and
minimal medium, size fractioning of the conditioned medium
was performed. Conditioned minimal medium was used because
size fractioning proved technically more challenging when ascites
was used; presumably due to the host proteins present. The effect
of a final concentration of: non-fractionated 10% conditioned or
unconditioned minimal medium, 10% fractionated conditioned
minimal media containing components ,3kD or .10kD, and
10% fractionated unconditioned minimal media containing
components ,10kD on the growth and/or survival of hvKP1 in
human ascites (batch 2) was assessed. The growth of hvKP1 was
significantly greater when grown in ascites supplemented with
non-fractionated conditioned minimal medium and fractionated
conditioned minimal medium containing components ,3kD
compared to when grown in ascites supplemented with non-
fractionated unconditioned minimal medium and fractionated
unconditioned minimal medium containing components ,10kD
respectively. Therefore, the molecule or factor that mediated the
growth and/or survival-enhancing effect was present in the
fractionated conditioned medium containing components ,3kD
(Figure 7A).
Next, the stability of the factor or molecule after heating to 56uC
for 30 minutes (D56uC) was assessed. The growth and/or survival
of hvKP1 was significantly increased when ascites was supple-
mented with either 5% conditioned or 5% conditioned medium
Figure 6. Neither LuxS generated AI-2 signaling molecules or the AI-3 signaling system appeared to affect the growth and/or
survival of hvKP1 in conditioned ascites. The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). Panel A: Ascites
was not supplemented (unconditioned) or supplemented with hvKP1 generated conditioned ascites (final concentration 5%) or hvKP1DluxS
generated conditioned ascites (batch 2) (final concentration 5%). There was no significant difference in the growth of hvKP1 when supplemented
with either of these conditioned media. Panel B: Ascites was not supplemented (unconditioned) or supplemented with hvKP1 generated conditioned
ascites (batch 2) (final concentration 5%) or epinephrine (final concentrations 50 mM and 500 mM). There was no significant difference in the growth
of hvKP1 with the addition of either of these supplements. Data are Mean 6 S.E.M.; N=2–3.
doi:10.1371/journal.pone.0026734.g006
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Therefore the described heat treatment did not affect the activity
of the molecule or factor in hvKP1-generated conditioned ascites
(Figure 7B).
An iron acquisition molecule(s) appears to be the
mediator in hvKP1 generated conditioned ascites and
minimal medium that enhances the growth and/or
survival of hvKP1
Although the small size and heat stability of the growth and/or
survival enhancing molecule or factor was consistent with an AI, it
also suggested the possibility that the observed effects were due to
an iron acquisition molecule such as a siderophore(s). Siderophores
have been increasingly recognized as critical secreted growth
factors in iron-limiting environments [36], which includes the
human host [37]. To assess this possibility, an approach utilized to
demonstrate that siderophores enable the growth of uncultured
bacteria was employed [36]. A limited number of molecules are
secreted by the laboratory E. coli strain BW25113 (wt). These
include the siderophore enterobactin [38], AI-2 molecules, and
indole, which can act as a signaling molecule [39]. Conditioned
medium from BW25113 and isogenic mutant derivatives deficient
in the production of enterobactin (BW25113DentB, BW25113
DentC), AI-2 molecules (BW25113DluxS), and indole (BW25113
DtnaA) was generated by overnight growth of these strains in
human ascites (batch 1) (heated to 56uC for 30 minutes since
BW25113 and derivatives are killed by complement-mediated
bactericidal activity present in ascites). Initial titration experiments
established that ascites containing a final concentration of 50%
conditioned ascites generated by BW25113 resulted in the optimal
growth of hvKP1 at a starting inoculum of approximately 10
3 cfu/
ml (data not shown). Growth of hvKP1 in ascites plus conditioned
ascites generated from BW25113, BW25113DluxS and BW
25113DtnaA was similar to that when conditioned ascites
generated from hvKP1 (5% final concentration, positive control)
was used (Figure 8A). By contrast, growth of hvKP1 in ascites plus
conditioned ascites generated from BW25113DentB and
BW25113DentC was significantly decreased compared to when
hvKP1 was grown in ascites supplemented with conditioned
ascites generated by the E. coli strains sufficient in enterobactin
production or with conditioned ascites generated by hvKP1
Figure 7. The mediators present in hvKP1 generated conditioned minimal medium and ascites that enhance the growth and/or
survival of hvKP1 are ,3kD and heat stable. The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2). Panel A:
Ascites was supplemented with either hvKP1 generated conditioned (cond) M9 minimal medium (MM) (10% final concentration) that was: 1) non-
fractionated (unfract), 2) ,3kD fraction, and 3) .10kD fraction or unconditioned (uncond) minimal medium (10% final concentration) that was: 4)
non-fractionated, and 5) ,10kD fraction. The growth and/or survival of hvKP1 was significantly increased when the ascites was supplemented with
10% conditioned, non-fractionated minimal medium or with 10% conditioned, ,3kD fraction of minimal medium compared to 10% unconditioned,
non-fractionated minimal medium and 10% unconditioned, ,10kD fraction of minimal medium respectively (* P,0.5/1). Data are Mean 6 S.E.M.;
N=2-3. Panel B: Ascites was not supplemented (unconditioned) or supplemented with hvKP1 generated conditioned (cond) ascites or with hvKP1
generated conditioned ascites that was heated at 56uC for 30 minutes (D56uC) (batch 2) (5% final concentration for both supplements). The growth
and/or survival of hvKP1 was significantly increased when ascites was supplemented with either conditioned or conditioned medium D56uC
compared to unconditioned ascites (* P,0.05/2). Data are Mean 6 S.E.M.; N=4.
doi:10.1371/journal.pone.0026734.g007
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enhance the growth and/or survival of hvKP1. The growth of hvKP1 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 1). Panel A:
Ascites was not supplemented (unconditioned) or supplemented with: 1) 5% hvKP1-generated conditioned (cond) ascites (batch 1) or 2) 50%
conditioned ascites generated from the E. coli laboratory strain BW25113 and isogenic derivatives deficient in the production of enterobactin
(BW25113DentB (CGSC#8704), BW25113DentC (CGSC#8702)), AI-2 molecules (BW25113DluxS (CGSC#10100)), and indole (BW25113DtnaA
(CGSC#8309)) (batch 1). The growth and/or survival of hvKP1 was significantly decreased when grown in ascites supplemented with conditioned
ascites generated by the E. coli strains deficient in enterobactin production compared to when grown in ascites supplemented with conditioned
ascites generated by the E. coli strains sufficient in enterobactin production or with conditioned ascites generated by hvKP1 (*P,0.05/4). Data are
Mean 6 S.E.M.; N=3. Panel B: Ascites (batch 1) was not supplemented (unconditioned) or supplemented with: 1) solvent alone (0.86% DMSO), 2) 5%
hvKP1-generated conditioned (cond) ascites (batch 1), or 3) 40nM, 80nM, 160nM, 320nM, 640nM, and 1.28 mM of purified enterobactin. The growth
and/or survival of hvKP1 was significantly increased when grown in ascites supplemented with 160nM, 320nM, 640nM, and 1.28 mM of purified
enterobactin (*P,0.05/6) and there was a trend for an increase with supplementation with 40nM and 80nM of purified enterobactin (
#P.0.05/6 and
,0.1) compared to growth and/or survival of hvKP1 grown ascites plus solvent alone. Data are Mean 6 S.E.M.; N=3–4. Panel C: Ascites (batch 2) was
not supplemented (unconditioned) or supplemented with 0.1mM of Fe (NO3)3, FeCl3, or FeSO4 , and 5% hvKP1 generated conditioned ascites. The
growth and/or survival of hvKP1 was significantly increased when grown in ascites supplemented with iron-containing compounds (*P,0.05/3). Data
are Mean 6 S.E.M.; N=2.
doi:10.1371/journal.pone.0026734.g008
Hypervirulent K. Pneumoniae and Virulence
PLoS ONE | www.plosone.org 8 October 2011 | Volume 6 | Issue 10 | e26734(Figure 8A). Essentially no growth of hvKP1 was observed in
ascites supplemented with a final concentration of 50% of
unconditioned ascites heated to 56uC for 30 minutes, which
served as a control for the addition of conditioned ascites diluting
complement-mediated bactericidal activity in ascites. Therefore,
these data demonstrate that the siderophore enterobactin, but not
AI-2 molecules or indole, can serve as a growth and/or survival-
enhancing factor for hvKP1 in human ascites.
To confirm that enterobactin can serve as a growth and/or
survival enhancing factor for hvKP1 in human ascites, hvKP1 was
grown in unconditioned human ascites (batch 1) at a starting
concentration of approximately 3–4610
3 cfu/ml to which solvent
alone (0.86% dimethyl sulfoxide (DMSO)) or 40nM, 80nM,
160nM, 320nM, 640nM, and 1.28 mM of purified enterobactin
(Sigma Life Sciences (Cat. No. 3910)) were added. The presence of
160nM, 320nM, 640nM, and 1.28 mM of purified enterobactin
significantly enhanced the growth of hvKP1 compared to the
solvent control (Figure 8B). These concentrations are below the
physiologic concentration of enterobactin (8 mM) secreted by an
extraintestinal pathogenic strain of E. coli [40].
Lastly, since the function of a siderophore is to acquire iron for
growth, the addition of iron added to unconditioned human ascites
would be hypothesized to enhance growth and/or survival of
hvKP1 in this medium. This hypothesis was substantiated when
the addition of 0.1mM of Fe (NO3)3, FeCl3, or FeSO4 to
unconditioned ascites (batch 2) significantly increased the growth
of hvKP1 compared to when these iron containing compounds
were not added (Figure 8C). Taken together these data
unequivocally demonstrate that the molecule or factor present in
conditioned ascites or minimal medium that enhances the growth
and/or survival of hvKP1 enables iron acquisition.
Compared to ‘‘classic’’ K. pneumoniae strains, hvKP1
appears to secrete either quantitatively more or
biologically more active mediators in ascites that
enhance the growth and/or survival of hvKP1
The data presented above (Figure 8B) demonstrated that the
siderophore enterobactin was able to enhance the growth and/or
survival of hvKP1 in ascites. Whether hvKP1 produces enter-
obactin is presently unknown, however, hvKP1 and cKP strains
undoubtedly produces a number of iron-acquisition molecules that
likely function in a similar fashion. Therefore, these data generated
the hypothesis that hvKP1 produces either quantitatively more or
biologically more active mediators of iron acquisition in ascites
that enhance its growth and/or survival in that medium compared
to cKP strains. To test this hypothesis hvKP1-generated and
‘‘classic’’ K. pneumoniae (cKP1-4)-generated conditioned ascites was
made in D56uC -ascites (batch 2). D56uC -ascites was used due to
the variable serum sensitivity of the strains (data not shown). The







cfu/ml for hvKP1, CKP1-4 respectively); establishing that
potential differences in the concentration of mediators was not
due to variability in bacterial load when the conditioned media
was processed. The effect of supplementing D56uC -ascites (batch
2) with 0%, 1%, 5%, or 25% of hvKP1 or cKP1-4 generated
conditioned ascites on the growth and/or survival of the four
‘‘classical’’ K. pneumoniae strains was assessed. Supplementation of
ascites with hvKP1 generated conditioned ascites significantly
increased the growth and/or survival of cKP1-4 compared to
when the ascites was supplemented with the homologous
conditioned ascites (Figure 9). This finding was consistently
observed despite the possibility that cKP strains may not possess
receptors for all of the iron-acquisition molecules secreted by
hvKP1. As expected, hvKP1-generated conditioned ascites
significantly enhanced the growth of itself compared to when
cKP-generated conditioned medium was used (data not shown).
Taken together, these data demonstrate that hvKP1 either
produces quantitatively more of this mediator(s) in ascites that
enhances its growth and/or survival in that medium or the
molecule(s)/factor(s) produced by hvKP1 are biologically more
active (increased affinity for iron or more resistant to host factors)
than those produced by cKP strains.
Compared to ‘‘classic’’ K. pneumoniae strains, hvKP1
secretes quantitatively more siderophores that also
appear to be biologically more active in ascites
To directly confirm that hvKP1 and cKP strains produce
siderophores and to assess whether hvKP1 produces more
siderophores than the cKP strains, a quantitative siderophore
assay was performed on the hvKP1 and cKP1-4 generated D56uC
-conditioned ascites used for the experiments described above
(Figure 9). The siderophore concentration of hvKP1 was 3 to 7
fold higher than cKP strains and these differences were
significantly different (P,0.05/4) (Table 1). These data, in
combination with the growth data presented above (Figure 9)
enabled us to determine if the effect of hvKP1 conditioned ascites
was solely due to having an increased concentration of side-
rophores or if the siderophores produced had an increased affinity
for iron or were more resistant to host factors designed to
inactivate siderophores. Examination of Figure 9 demonstrates
that supplementation of ascites with 5% hvKP1 conditioned
ascites resulted in higher growth of cKP1-4 compared to when
ascites was supplemented with 25% cKP1-4 conditioned ascites.
Based on quantitative siderophore concentration data (Table 1),
the calculated siderophore concentrations in 25% cKP1-4
conditioned ascites were 4.469 mg/mL, 1.950 mg/mL, 3.221 mg/
mL, and 2.754 mg/mL respectively. The calculated siderophore
concentration in 5% hvKP1 conditioned ascites was 2.738 mg/
mL. Therefore, in 3 of 4 instances (cKP1, cKP3, cKP4) 5% hvKP1
conditioned ascites promoted greater bacterial growth despite less
or similar amounts of siderophores being present when compared
to 25% cKP1-4 conditioned ascites (Table 1). These data strongly
support the concept that in addition to producing quantitatively
more siderophores, hvKP1 produces biologically more active
siderophores. The nature of increased activity is unknown, but one
can postulate that siderophores produced by hvKP1 possess an
increased stability against host defense mechanisms or heightened
efficiency in iron-acquisition in host environment.
Discussion
Our understanding of the pathogenesis of hvKP, the responsible
virulence factors, and the means by which its virulence is enhanced
compared to cKP has just begun. Clearly the genotype and
phenotype of hvKP has evolved, however the nature of this change
is poorly understood. cKP strains appear to be genomically distinct
from hvKP [41,42], despite sharing some common virulence
factors with hvKP strains. The presence of a hypermucoviscous
phenotype and selected capsular serotypes (primarily serotypes K1
or K2), were initially proposed to be defining characteristics of
hvKP [2,7,43]. The hypermucoviscous phenotype is an important
virulence factor for K. pneumoniae [44], regardless of the capsule
serotype [45]. The majority, but not all of the strains that cause
CA-PLA possess the gene that confers this phenotype, rmpA
[41,43,45,46]. The biochemical nature of the hypermucoviscous
phenotype is unclear but appears to be distinct from the
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polysaccharide colanic acid [44]. In some strains, rmpA is present
on a large virulence plasmid and may be a surrogate marker for
other virulence factors [44,47]. However, recent genomic
characterizations established that the genomic background, rather
than the hypermucoviscous phenotype defines hvKP pathogenicity
[41,42,48]. The capsule, especially serotypes K1 and K2, has long
been known to be an important virulence factor in cKP
[49,50,51,52,53]. Because the majority of hvKP strains that
caused CA-PLA were either a K1 or K2 serotype, these capsular
serotypes were initially believed to be the critical virulence factors
in this infectious syndrome [7,43]. However, 23–33% of strains
that cause CA-PLA are non-K1/K2 isolates [43,45,54]. Further,
since the K1 and K2 serotypes were also present in non-CA-PLA
clonal groups that were significantly less virulent in a mouse
model, the authors concluded that the pathogenic potential of CA-
PLA isolates resides with their genomic background, not the
capsular serotype [41]. These data do not exclude capsule as an
Table 1. Siderophore concentration in hvKP1 and cKP1-4 generated conditioned ascites.
Measured Mean ± SEM (mg/mL)
Calculated concentration in 25% conditioned ascites for
cKP1-4 and 5% for hvKP1





*P,0.05/4 , hvKP1 compared to cKP1-4.
doi:10.1371/journal.pone.0026734.t001
Figure 9. hvKP1 generated conditioned ascites is a more potent enhancer of growth/survival in ascites of cKP1-4 than cKP1-4
generated conditioned ascites. The growth of cKP1-4 was assessed at 0, 3, 6, and 24 hours in human ascites (batch 2) that was heated at 56uC for
30 minutes (D56uC) and supplemented with 0%, 1%, 5%, or 25% of hvKP1 or cKP1-4 generated conditioned D56uC ascites. Panel A: cKP1; there was a
trend for increased growth and/or survival of cKP1 when ascites was supplemented with 25% hvKP1-generated conditioned ascites compared to 25%
cKP1-generated conditioned ascites (#P.0.05/3 but ,0.05). Panel B: cKP2; the growth and/or survival of cKP2 was significantly increased when
ascites was supplemented with 25% hvKP1-generated conditioned ascites compared to 25% cKP2-generated conditioned ascites (*P,0.05/3). Panel
C: cKP3; the growth and/or survival of cKP3 was significantly increased when ascites was supplemented with 1% hvKP3-generated conditioned
ascites compared to 1% cKP3-generated conditioned ascites (*P,0.05/3) and there was a trend for increased growth and/or survival of cKP1 when
ascites was supplemented with 5% and 25% hvKP1-generated conditioned ascites compared to 5% and 25% cKP1-generated conditioned ascites
(#P.0.05/3 but ,0.05). Panel D: cKP4; there was a trend for increased growth and/or survival of cKP4 when ascites was supplemented with 1%
hvKP1-generated conditioned ascites compared to 1% cKP4-generated conditioned ascites (#P.0.05/3 but,0.05). Data are Mean 6 S.E.M.; N=4.
doi:10.1371/journal.pone.0026734.g009
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taken together these data support the concept that genes that
encode for non-capsular virulence factors are important in the
hypervirulent phenotype of hvKP.
In this report a new mechanism that enhances virulence is
described. A molecule(s)/factor secreted by hvKP1 significantly
enhances its growth and/or survival in human ascites and serum
ex vivo and in an mouse infection model that measures metastatic
spread after subcutaneous challenge. Although features such as a
size of ,3kD, heat stability, and growth characteristics in ascites
suggested this molecule(s) was a quorum-sensing compound, it
proved to be a molecule(s)/factor(s) is involved in iron uptake and
is likely a siderophore(s) or another unique iron-acquisition
molecule. Although it is known that iron acquisition is critical
for virulence, a novel aspect of this observation is that hvKP1
produces quantitatively more siderophores that appear to be
biologically more active (increased affinity for iron or more
resistant to host factors) than those produced by cKP strains. We
are unaware of any published data that considers the virulence
potential of a pathogen is quantitatively linked to its iron-
acquisition capacity or whether specific iron-acquisition systems
are biologically more or less active in Klebsiella. Although
increased production of iron acquisition factors could be due to
a mutation in the negative regulator Fur, this is unlikely.
Supplementation of ascites with hvKP1 generated conditioned
LB medium (which is iron replete and therefore Fur repression is
active) does not increase its growth and/or survival (Figure 3). This
finding is consistent with the normal expression of iron-regulated
genes in hvKP1. If in future studies the increased virulence of
hvKP can be attributed to specific iron-acquisition molecules, then
these compounds would represent potential therapeutic targets or
targets for active or passive immunization.
Data presented demonstrates that the addition the siderophore
enterobactin to human ascites can enhance the growth and/or
survival of hvKP1 in that medium (Figure 8B). But the identity of
the molecules(s)/factors(s) secreted specifically by hvKP1 and
which serve the same purpose remain undefined. Limited data
exists on which factors are present in hvKP versus cKP strains. A
bioinformatics analysis of NTUH-K2044, the only sequenced
hvKP strain with a completed genome, demonstrated that it
possessed on the integrative element ICEKp1 orthologues for the
siderophore yersinibactin and the siderophore receptor IroN that
were not present on the genome of the cKP MGH78578 [42]. In
another report, gene clusters for the yersinia high pathogenicity
island, iucABCDiutA, iroNDCB, and hmuRSTUV, which encode for
iron acquisition systems were identified as being more prevalent in
hvKP than cKP isolates[55]. The Kfu system has also been shown
to be more prevalent in hvKP strains compared to cKP isolates
[56]. Ongoing studies are focusing on the nature and quantity of
the mediators present in hvKP1-generated conditioned ascites.
Unlike quorum sensing systems in which AI can self-amplify
their production, iron-acquisition systems are iron-regulated and
do not autoinduce. Since the concentration of the iron-acquisition
mediators produced by hvKP1/cell in the fixed volume of our
assay should be the same at low and high titers, it was curious that
growth and/or survival only occurred at high titer (Figure 1). One
theory would be that ascites contains a host molecule that is
capable of binding and inactivating the bacterial iron-acquisition
molecules. The host protein lipocalin 2 possesses these properties
[57]. Lipocalin 2 would be predicted to be present in ascites. If so,
one could hypothesize that when hvKP1 is present in ascites at
lower titers the concentration of lipocalin 2 may be sufficient to
bind an adequate amount of iron-acquisition mediators to inhibit
growth. However by contrast, when hvKP1 is present at a high
titer then the concentration of iron-acquisition mediators may
exceed the binding capacity of lipocalin 2. This may also be
another mechanism that might explain the effect of inoculum on
the development of infection. However, once infection is
established, one would predict that hvKP is now capable of
acquiring iron in a more efficient fashion, which in turn will
enhance its ability to grow and/or survive host defenses. This
feature may be an explanation for its propensity for metastatic
spread from the original site of infection. Further, under conditions
in which iron is more available such as hemolysis, tissue necrosis,
or a local anaerobic environment, the ability to grow and the
overall virulence of hvKP would be predicted to increase and
therefore initial infection could be established with a lower
bacterial inoculum. These hypotheses are presently being tested.
In summary, the data presented delineates a new mechanism by
which hvKP increases its pathogenic potential compared to cKP
strains. It is mediated by the ability of hvKP1 to produce
quantitatively more and biologically more active iron-acquisition
molecule(s)/factor(s) than those produced by cKP strains. It should
be noted that this mechanism possesses features of quorum sensing
with which it can be confused. This paradigm may be broadly
applicable to other extraintestinal gram-negative bacilli.
Materials and Methods
Ethics statement
The mouse subcutaneous (SQ) infection model studies was
reviewed and approved by the Western New York Veterans
Administration Institutional Animal Care Committee. This study
was carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of
the National Institutes of Health and all efforts were made
to minimize suffering. The procedures for obtaining human
serum and ascites were reviewed and approved by the Western
New York Veterans Administration Institutional Review Board.
Informed consent was used to obtain human blood for the
preparation of serum (approval ID # 00063). The Western New
York Veterans Administration Institutional Review Board for the
process of obtaining ascites waived informed consent (approval
ID # 00098). An expedited review was performed because the
ascites was collected from de-identified patients who were under-
going therapeutic paracentesis for symptoms due to abdominal
distension.
Strain description
hvKP1 was isolated from the blood and liver abscess in a
previously healthy 24 yo male from Buffalo, New York, USA with
CA-PLA and metastatic spread to the spleen [6]. It possesses a K2
serotype and is hypermucoviscous. A luxS homolog (ygaG) was
identified in hvKP1 and a LuxS deficient derivative (hvKP1DluxS)
was generated by allelic exchange as described [58]. The E. coli
laboratory strain BW25113 and isogenic derivatives deficient in
the production of enterobactin (BW25113DentB (CGSC#8704),
BW25113DentC (CGSC#8702)), AI-2 molecules (BW25113DluxS
(CGSC#10100)), and indole (BW25113DtnaA (CGSC#8309))
were obtained from the Keio Collection knockout library [59].
Media
hvKP1 was maintained at 280uC in 50% Luria-Bertani (LB)
broth and 50% glycerol. Human ascites was collected from
individuals were not being treated with antimicrobials and were
not infected with human immunodeficiency, hepatitis B and
hepatitis C viruses. The ascites was cultured to confirm sterility,
divided into aliquots, and stored at 280uC. Each batch was
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removal; batch 1 (12/2007) and batch 2 (8/2009). For various in
vitro growth studies 100% ascites, Luria-Bertani medium and M9
minimal medium was used.
In vitro growth in ascites, LB and M9 minimal medium
Growth in these media were performed as described with
aliquots removed for bacterial enumeration at 0, 3, 6 and 24 hours
[30].
Development of conditioned medium
The bacterial strains, from which conditioned medium was
being generated, were grown overnight in ascites, LB or M9
medium (supplemented with antibiotics when appropriate), using a
starting inoculum of .1610
7 cfu/ml. Aliquots of the overnight
cultures were removed for bacterial enumeration. The cultures
were then centrifuged at 70006g for 10 minutes at 4uC. The
supernatants were initially passed through a 0.45 mm and then
subsequently through a 0.2 mm syringe filter (Corning Inc., Part
No. 431229, PES membrane) and stored as aliquots at 280uC.
For some experiments conditioned medium was size fractionated
using centrifugal filter devices with molecular weight cut-offs of 3
and 10kD (Centricon, Millipore Corp., Bedford, MA).
Serum bactericidal assay
Complement-mediated bactericidal assays were performed at a
starting inoculum of approximately 1610
5 cfu/ml as described
except that aliquots were removed for bacterial enumeration at 0,
3, 6 and 24 hours [6,29,30]. Growth in heat inactivated serum
served was a positive control that established that decreased
survival was due to complement-mediated bactericidal activity.
Mouse subcutaneous challenge infection model
This model was developed for the in vivo evaluation of hvKP
since these strains are capable of gaining entry into the human host
via this route, making this model clinically relevant. However,
even if hvKP enters the human host through another site (e.g.
intestinal tract), SQ challenge will enable an evaluation of the
extraintestinal phase of the infectious process. Further and
importantly, this route of infection will result in bacteria entering
the bloodstream at a physiologically appropriate titer, which in
turn, will result in an appropriate host inflammatory response. SQ
challenge with an appropriate dose of hvKP1 results in systemic
infection. Male CD1 mice (18–22 grams) are challenged SQ with
hvKP1. A total of six animals were used per group with three
animals from each group euthanized at 24 and 48 hours post-
bacterial challenge, after which blood, lungs, kidneys, liver, spleen,
and eyes are harvested for enumeration of bacterial colony
forming units (cfu). First, blood is obtained from the left ventricle
for culture. Next, the right atrium is incised and 5ml of 1x PBS is
injected through the left ventricle so that the entire blood volume is
flushed from the vasculature. Subsequently, organs are harvested.
In this manner bacterial counts solely reflect organ-specific cfu.
Confirmation of the phenotype of hvKP1 DluxS
A bioassay, using the reporter strain BB170 (ATCC number




+), was used as described
[60] to confirm that luxS (ygaG) was successfully disrupted in
hvKP1DluxS. In brief, BB170 was grown in autoinducer bioassay
medium [61] and was exposed to sterile conditioned media
generated from the overnight growth of the following strains in
autoinducer medium: 1- positive control: BB120 (ATCC number
BAA-1116; WT, AI-1 sensor-positive, AI-2 sensor 2-positive, AI-
1
+ AI-2
+, parent of BB170), 2- negative controls: E.coli strains
DH5a (luxS-minus) and JW2662-1 (CGSC#10100, Keio Collec-
tion, luxS-minus), and 3 - strains to be tested: hvKP1 and
hvKP1DluxS. Light production was measured every 30 minutes,
from 0 to 6 hours using a LUMAT luminometer (Berthold
GmbH, Germany, LB 9501). The response of BB170 to the
conditioned media from the controls was as expected (data not
shown). BB170 produced light in response to the conditioned
medium from hvKP1, but by contrast, not from hvKP1DluxS (data
not shown). These data validated the phenotype of hvKP1DluxS.
Quantitative siderophore assay
The siderophore concentration in conditioned ascites generated
by cKP1-4 and hvKP1 used to assess the effect of hvKP1
conditioned medium and the homologous conditioned medium on
the growth of each of the respective cKP strains (Figure 9) was
determined using the SideroTec assay (Emergen Bio, Maynooth,
Ireland). Standards were prepared by serial dilution of the
standard with diluent and were 0, 1.3, 3.1, 6.25, 12.5, 25, 50,
and 100 mg/mL. In a flat-bottom 96-well plate, 100 mL of each
standard and conditioned ascites were added into wells containing
the catalyst reagent (diluted 1:10 in the dye reagent). The reaction
was incubated for 10 minutes, then read every 5 minutes at
630 nm until 50 minutes. For quantitative interpretation, a
reference curve was calculated as follows: (OD standard/OD
zero standard) x 100. A curve was generated using cubic spline
analysis in Prism software. The siderophore concentration in each
sample was extrapolated from the reference curve. The incubation
time that resulted in the highest concentration for a given sample
was used for quantitation, which was 10 minutes for conditioned
ascites generated by cKP2-4 and 45 minutes for conditioned
ascites generated by cKP1 and hvKP1.
Statistical Analyses
Data are presented as mean 6 SEM. P values of 0.05/n (n=
the number of comparisons) are considered statistically significant
based on the Bonferroni correction for multiple comparisons, and
P values .0.05/n but ,0.1 are considered as representing a trend.
To normalize in vitro and in vivo data log10 transformed values were
utilized, the area under each curve was calculated, and these areas
compared using two-tailed unpaired t tests (Prism 4 for MacIntosh,
GraphPad Software Inc.).
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